Direkt zum Inhalt
Merck
  • Unfolded protein response prevents blastocyst formation during preimplantation embryo development in vitro.

Unfolded protein response prevents blastocyst formation during preimplantation embryo development in vitro.

Fertility and sterility (2014-10-13)
Murat Basar, Idil Bozkurt, Ozlem Guzeloglu-Kayisli, Berna Sozen, Isil Tekmen, Frederick Schatz, Aydin Arici, Charles J Lockwood, Umit A Kayisli
ZUSAMMENFASSUNG

To study the effect of increased endoplasmic reticulum (ER) stress as a major nongenomic mechanism for arrested blastocyst development. Cell and animal study. The Ohio State University and Yale University. Mice. Pregnant mare serum gonadotropin and hCG were administered IP; two cell embryos were collected 48 hours after hCG administration. Blastocyst development rate. No morphological difference was detected in control versus tunicamycin- (TM) treated embryos until the blastocyst stage. On day 4 of embryonic development, TM treatment reduced blastocyst formation from 79% to 4% and induced nuclear fragmentation. TM treatment caused 2-fold and 2.6-fold increase in binding immunoglobulin protein and spliced-X-box binding protein 1 mRNA expression, respectively. By comparison, the tauroursodeoxycholic acid + TM combination reversed the effect of TM alone on blastocyst formation to near control levels. These results indicate that increased ER stress during in vitro embryo development triggers an unfolded protein response (UPR) that negatively affects blastocyst formation and suggests that activation of UPR signaling may account for low rates of blastocyst development.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Glycin, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
Glycin, suitable for electrophoresis, ≥99%
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Glycin, BioUltra, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
Glycin, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
SAFC
Glycin
USP
Glycin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Glycin, BioXtra, ≥99% (titration)
Sigma-Aldrich
Glycin, 99%, FCC
Sigma-Aldrich
Glycin, ACS reagent, ≥98.5%
Supelco
Glycin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glycin, meets analytical specification of Ph. Eur., BP, USP, 99-101% (based on anhydrous substance)
Supelco
Glycin, analytical standard, for nitrogen determination according to Kjeldahl method
Sigma-Aldrich
Glycin, puriss. p.a., reag. Ph. Eur., buffer substance, 99.7-101% (calc. to the dried substance)
Glycin, European Pharmacopoeia (EP) Reference Standard
Supelco
Glycin, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Glycin, tested according to Ph. Eur.